Scientists test rapamycin to slow aging in dogs #shorts

Summary

The main theme is exploring rapamycin as a potential treatment for cognitive decline and dementia, inspired by its success in mice. This pilot study examined the drug's effect on a small group of aging dogs, noting a reduction in inflammation-associated microglial cells in their brains. The practical takeaway suggests that rapamycin may help extend life and improve cognition in dogs, paving the way for larger human trials.